MOLECULAR PROFILING OF THE EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) PATHWAY IN THE MANAGEMENT OF ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS (PTS)

被引：0
|
作者：
Nuzzo, C. [1 ]
Sperduti, I. [2 ]
Marchetti, A. [3 ]
Cianciulli, A. M. [2 ]
Mottolese, M. [2 ]
Buttitta, F. [3 ]
Visca, P. [1 ]
Cecere, F. L. [4 ]
Cognetti, F. [1 ]
Milella, M. [1 ]
机构：
[1] Regina Elena Inst Canc Res, Rome, Italy
[2] Regina Elena Inst Canc Res, Rome, Italy
[3] Univ G dAnnunzio, Chieti, Italy
[4] IFO Regina Elena Natl, Div Med Oncol A, Rome, Italy
来源：
ANNALS OF ONCOLOGY | 2008年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：105 / 105
页数：1
相关论文
共 50 条
  • [31] Clinical implications of routine testing for epidermal growth factor receptor (EGFR) mutations in patients with nonsquamous non-small cell lung cancer (NSCLC)
    Zhu, Hui
    Arrossi, Andria Valeria
    Elson, Paul
    Farver, Carol
    Tubbs, Raymond R.
    Murthy, Sudish C.
    Mason, David P.
    Mazzone, Peter J.
    Pennell, Nathan A.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [32] Impact of clinical features of epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC) patients on osimertinib efficacy
    Lazzari, Chiara
    Gregorc, Vanesa
    Santarpia, Mariacarmela
    JOURNAL OF THORACIC DISEASE, 2019, 11 (11) : 4400 - 4403
  • [33] Can the epidermal growth factor receptor (EGFR) expression predict survival in surgically resected non-small cell lung cancer (NSCLC) patients?
    Gately, Kathy A.
    Coate, Linda
    Cuffe, Sinead
    Pidgeon, Graham
    O'Byrne, Kenneth
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S906 - S906
  • [34] European prevalence of Epidermal Growth Factor Receptor (EGFR) mutations in patients with Non-small Cell Lung Cancer (NSCLC): A meta-analysis
    Haentschel, M.
    Kambartel, K.
    Melosky, B.
    Cappuzzo, F.
    Bennetts, M.
    Nickens, D. J.
    Brinkmann, J.
    Kayser, A.
    Moran, M.
    Laack, E.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 143 - 144
  • [35] Gefitinib Therapy in Patients With Advanced Non-Small Cell Lung Cancer With or Without Testing for Epidermal Growth Factor Receptor (EGFR) Mutations
    Wu, Jenn-Yu
    Shih, Jin-Yuan
    Chen, Kuan-Yu
    Yang, Chih-Hsin
    Yu, Chong-Jen
    Yang, Pan-Chyr
    MEDICINE, 2011, 90 (03) : 159 - 167
  • [36] Non-small cell lung cancer (NSCLC) patients with rare or complex epidermal growth factor receptor (EGFR) mutations: A single institution series
    Pasello, G.
    Polo, V.
    Frega, S.
    Lorenzi, M.
    Indraccolo, S.
    Fassan, M.
    Bonanno, L.
    Nannini, N.
    Conte, P. F.
    Calabrese, F.
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (04) : S130 - S130
  • [37] Epidermal growth factor receptor (EGFR) mutations in the serum of non-small cell lung cancer (NSCLC) patients as a marker to select patients for targeted therapy
    Mohan, Anant
    Ansari, Ashraf
    Masroor, Mirza
    Saxena, Alpana
    Pandey, Ravinder. M.
    Upadhyay, Ashish
    Luthra, Kalpana
    Khilnani, Gopi. C.
    Jain, Deepali
    Kumar, Rakesh
    Guleria, Randeep
    INDIAN JOURNAL OF CANCER, 2024, 61 (03) : 495 - 501
  • [38] EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) CO-MUTATED ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) AND RESPONSE TO EGFR TYROSINE KINASE INHIBITORS (TKIS)
    Barnet, Megan B.
    O'Toole, Sandra
    Horvath, Lisa' G.
    Selinger, Christina
    Yu, Bing
    Trent, Ronald
    Ng, Chiu Chin
    Boyer, Michael J.
    Cooper, Wendy
    Kao, Steven
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 : 156 - 156
  • [39] Optimal Management of Patients with Non-Small Cell Lung Cancer and Epidermal Growth Factor Receptor Mutations
    Chia-Chi Lin
    James Chih-Hsin Yang
    Drugs, 2011, 71 : 79 - 88
  • [40] Optimal Management of Patients with Non-Small Cell Lung Cancer and Epidermal Growth Factor Receptor Mutations
    Lin, Chia-Chi
    Yang, James Chih-Hsin
    DRUGS, 2011, 71 (01) : 79 - 88
12345